throbber
Materials Considered by Nandita Das, Ph.D.
`
`U.S. Patent No. 8,475,832 (filed August 7, 2009)
`
`File History, U.S. Patent No. 8,475,832
`
`U.S. Patent No. 5,288,497 (“Stanley”)
`
`U.S. Patent No. 4,582,835
`
`U.S. Patent No. 7,357,891 (“Yang”)
`
`U.S. Patent App. No. US 2010/0087470
`
`U.S. Patent Application Publication 2005/0085440 (published April 21, 2005)
`(“Birch”)
`
`U.S. Patent Application Publication No. 2005/0037055 (“the ’055 publication”)
`
`WO 2008/025791 (published March 6, 2008) (“Oksche”)
`
`WO 2008/040534 (published April 10, 2008) (“LabTec”)
`
`Suboxone® Label
`
`Suboxone® Tablet Summary Basis of Approval (“SBOA”)
`
`European Medicines Agency Initial Marketing-Authorisation Document, Scientific
`Discussion, Oct. 19, 2006 for Suboxone sublingual tablets (“EMEA”)
`
`Center for Drug Evaluation and Research, Approval Package for App. No. 22-
`410/S006/S007 (approval date 8/10/12) (“Film Approval Package”).
`J.P. Cassidy et al., Controlled Buccal Delivery of Buprenorphine, 25 J. Controlled
`Release 21 (1993) [“Cassidy”]
`Rex M. C. Dawson et al., Data for Biochemical Research (3d ed. 1986)
`
`Domenic A. Ciraulo et al., Pharmacokinetics and Pharmacodynamics of Multiple
`Sublingual Buprenorphine Tablets in Dose-Escelation Trials, 46 J. Clinical
`Pharmacology 179 (2006)
`
`C. Nora Chiang & Richard L. Hawks, Pharmacokinetics of the Combination Tablet
`of Buprenorphine and Naloxone, 70 Drug & Alcohol Dependence S39 (2003)
`
`
`
`TEVA EXHIBIT 1026
`TEVA PHARMACEUTICALS USA, INC. V. RB PHARMACEUTICALS LTD.
`
`

`
`
`
`Materials Considered by Nandita Das, Ph.D.
`
`Campbell et al., The History of the Development of Buprenorphine as an Addiction
`Therapeutic, 1248 Ann. N.Y. Acad. Sc. (Issue: Addiction Reviews), 124 (2012)
`(“Campbell”)
`
`Bullingham et al., Sublingual Buprenorphine Used Postoperatively: Clinical
`Observations and Preliminary Pharmacokinetic Analysis, 12 Br. J. Clinical
`Pharmacology 117 (1981)
`Encyclopedia of Pharmaceutical Technology, 2nd ed., Vol. I, Drug Delivery—
`Buccal Route (McElnay et al.) (“McElnay”)
`
`Inter partes Review (“BDSI”) of U.S. Pat. No. 8,475,832, Decl. by Maureen
`Reitman, SC.D., Ex. 100_at 3 (“Reitman Decl.”).
`
`Parkhurst A. Shore et al., The Gastric Secretion of Drugs: A pH Partition
`Hypothesis, 119 J. Pharmacology Exp. Ther. 361 (1957)
`
`
`
`
`
`2
`
`TEVA EXHIBIT 1026
`TEVA PHARMACEUTICALS USA, INC. V. RB PHARMACEUTICALS LTD.

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket